How Does NGM Biopharmaceuticals Inc (NGM) Stock Rank on Wall Street Thursday?

Thursday, April 28, 2022 03:29 PM | InvestorsObserver Analysts

Mentioned in this article

How Does NGM Biopharmaceuticals Inc (NGM) Stock Rank on Wall Street Thursday?

Wall Street is positive on NGM Biopharmaceuticals Inc (NGM). On average, analysts give NGM Biopharmaceuticals Inc a Strong Buy rating. The average price target is $35.2, which means analysts expect the stock to add by 164.86% over the next twelve months. That average ranking earns NGM Biopharmaceuticals Inc an Analyst Rating of 72, which is better than 72% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating NGM a Strong Buy today. Find out what this means to you and get the rest of the rankings on NGM!

See Full NGM Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With NGM Biopharmaceuticals Inc Stock Today?

NGM Biopharmaceuticals Inc (NGM) stock is down -8.66% while the S&P 500 is higher by 2.79% as of 3:26 PM on Thursday, Apr 28. NGM has fallen -$1.26 from the previous closing price of $14.55 on volume of 407,694 shares. Over the past year the S&P 500 has risen 2.81% while NGM has fallen -53.58%. NGM lost -$1.56 per share the over the last 12 months. Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.